Drug Approval | December 19, 2022
Sun Pharmaceutical receives warning letter from USFDA for Halol facility
The Halol facility was placed under Import Alert by USFDA.
The Halol facility was placed under Import Alert by USFDA.
The newly built centre will work as the state-of-the-art facility for not just ethical animal studies but spans from basic, applied to regulatory animal research.
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
Ayúdame3D has become a leading social entity in social technology.
The company will submit an action plan on the observations and will engage with US FDA for next steps.
The designation recognizes Seeq's expertise in enabling faster insights and better business outcomes for life sciences customers, including Bristol Myers Squibb, with advanced analytics innovations.
This partnership stemmed from a successful customer-supplier relationship spanning several years.
Desonide Cream, 0.05%, has an estimated market size of US $12 million for twelve months ending Sep 2022 according to IQVIA
Diclofenac Sodium Topical Solution, 2% w/w (RLD PENNSAID) had estimated annual sales of US $509 million in the US (IQVIA MAT October 2022)
The company will set-up a pharmaceuticals formulation manufacturing unit with an investment of Rs. 100 crore in Odisha
Subscribe To Our Newsletter & Stay Updated
